WASHINGTON—The first treatment for peanut allergies is about to hit the market, a big step toward better care for all kinds of food allergies—but still a long way from a cure.
Friday’s approval by the Food and Drug Administration promises to bring some relief to families who’ve lived in fear of an accidental bite of peanuts at birthday parties and play dates, school cafeterias, and restaurants. Named Palforzia, it was developed by Aimmune Therapeutics.
